AIMBE Inducts Aijun Wang into College of Fellows for Outstanding Contributions

The American Institute for Medical and Biological Engineering, or AIMBE, has inducted Aijun Wang, a professor of biomedical engineering at the University of California, Davis, into its esteemed College of Fellows today. The formal ceremony was held at the Renaissance Arlington Capital View Hotel in Arlington, Virginia. 

Election to AIMBE's College of Fellows represents one of the greatest distinctions given to medical and biological engineers, as it is reserved for the top two percent of individuals making outstanding contributions to these fields, from advancing engineering research to pioneering new types of biomedical technology. Members include Nobel laureates and awardees of the Presidential Medal of Science, among recipients of other signal honors.  

The College of Fellows elected Wang for his outstanding contributions to stem cell engineering and tissue regeneration applications, which include his groundbreaking work on a spina bifida treatment, the invention of a device to help kidney disease patients on hemodialysis, the development of a bioengineered scaffold to quicken recovery time after deep burn wounds and his research into extracellular vesicles as a next-generation drug platform. 

"I'm very proud to join the College of Fellows," Wang said. "It's a tremendous honor and recognition of my achievements."  

Wang extended the recognition to his lab, explaining that his achievements are only possible because of the efforts from his lab members, mentees, mentors and collaborators.  

"All the work," he said, in reference to his research in stem cell engineering, "it's not done just by me. It has really been thanks to a team science approach that we've carried through with all these projects." 

This mentality is something that Wang wants to bring to the College of Fellows, as he looks forward to collaborating with many of the leading engineers to address more unmet medical needs.  

He's also very excited about the opportunity to promote public policies that foster continued advancement in medical and biological engineering.  

"As recognized leaders, we fellows should and will educate and influence public officials, regulators, the media and the general public to make sure it's known that medical and biological engineering is changing the world and making a positive impact on both improving human health and contributing to a vibrant economy."